New, Promising Clinical Trial for Glioblastoma Starting at UNC Health
November 08, 2023
November 08, 2023
CHAPEL HILL, North Carolina, Nov. 8 (TNSres) -- The University of North Carolina School of Medicine issued the following news release:
* * *
UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.
* * *
UNC Health is now enrolling patients as part of a multicenter . . .
* * *
UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.
* * *
UNC Health is now enrolling patients as part of a multicenter . . .